SlideShare a Scribd company logo
Presentation 
on 
“Method Development and validation for the 
Quantitative Estimation of ONDANSETRON 
HYDROCHLORIDE by HPTLC in Bulk Drug & 
Tablet Dosage Form” 
By: LOVE KUMAR 
M.Sc Biotechnology
What is Drug? 
• Drug is substance meant for cure, mitigation 
prevention or treatment of disease. 
• A drug is a substance which may have 
medicinal, intoxicating, performance 
enhancing or other effects when taken or put 
into a human body.
ONDANSETRON HYDROCHLORIDE 
• Ondansetron hydrochloride is a serotonin 5- 
HT-3 receptor antagonist used mainly as an 
antiemetic to treat nausea and vomiting
Mechanism of action 
• It effects on both peripheral and central nerves system by 
reducing the activity of the vagus nerve which deactivate the 
vomiting centre in the medulla oblongota and also block 
serotonin receptors in the chemoreceptor trigger zone 
• It also has little effect on vomiting caused by motion sickness.
ondansetron hydrochloride 
• 1. Nature : Amorphous 
• 2. Colour : White 
• 3. Odour : Odourless 
• 4. Taste : Bitter 
• 5. Melting point : 1200 C 
• 6. Solubility : freely soluble in methanol
Method Development 
• Existing method may not be suitable. 
• Unreliable 
• Expensive 
• Time consuming 
• Not Easily automated 
• New instrumentation technique may provide 
improved methods
CHROMATOGRAPHY 
• The term ‘Chromatography’ covers those 
processes aimed at the separation of the 
various species of a mixture on the basis of 
their distribution characteristics between a 
stationary and a mobile phase.
Different modes of chromatography are as 
follows: 
• Normal Phase Chromatography 
• Reversed Phase Chromatography 
• Reversed Phase – Ion pair Chromatography 
• Ion Chromatography 
• Ion-Exchange Chromatography 
• Affinity Chromatography 
• Size Exclusion Chromatography
Instrumentation 
Pump 
Injector 
Silica Plate 
Detector 
Gradient 
Controller 
Mobile Phases 
•
Materials and Method 
Reagents and Chemicals: 
• Sample and working standards of ondansetron hydrochloride 
were obtained from Sun Pharma Pvt Ltd, HPLC grade 
methanol was purchased from E.Merck and ammonium acetate 
of analytical reagent grade was purchased from Sisco Research 
Laboratories. 
Instrumentation: 
• Uv –vis spectrophotometer is of backman DU640B 
• Pump - water 600controller pump 
• Auto sampler – water 717 plus 
• Uv detector – water 486 
• Software – millinium 32 .
Chromatographic Conditions 
• The elution of ondansateron hydrochloride was obtained by running 
HPTLC in isocratic mode using methanol and tiriethylamine – 
glacial acetic acid in a ratio of 9.5:0.5 v/v, flowrate was maintained 
at 1.0 ml per minute with run time of 10 minutes. 
• The Rf for ondansateron hydrochloride was obtained at 7.7 and 
detection was performed at 309 nm. 
• Mobile phase was previously filtered through what mann filter paper 
no 41.
• Preparation of Standard Stock solution 
• Stock solution (1000 ppm) of ondansateron hydrochloride was 
prepared by dissolving 100 mg of Eslicarbazepine Acetate 
standard in methanol in a 100 ml volumetric flask, the volume 
was made up to the mark with methanol. 
• This stock solution was further diluted to obtain desired 
concentrations. 
• Preparation of Sample solution: 
• Weighed 20 tablets of ondansateron hydrochloride (labelled 
claim 400 mg of ondansateron hydrochloride ) and average 
weight was calculated. 
• The tablets were crushed to get homogenous powder and a 
quantity equivalent to 100 mg was weighed in a volumetric flask. 
• The powder was then allowed to dissolve in methanol by 
sonication. Make up the volume to the mark with methanol and 
filter the solution through 0.2 μm filters. 
• The filtrate was diluted to obtain desired concentrations.
Method Development: 
Selection of wavelength 
• Appropriate dilutions of ondansateron hydrochloride was 
prepared from the stock solution,which were scanned over a 
range of 200-400 nm and the UV spectrum was . 
• The maximum absorbance was found at 309 nm.
Method Validation 
• Linearity 
• Sensitivity 
• Precision 
• Accuracy 
• Limit of Detection (LOD) 
• Limit of Quantitation (LOQ) 
• Ruggedness 
• Robustness 
• Stability 
• System Suitability
Precision 
• Precision of an analytical procedure referred to degree of 
scatterness between a series of observations obtained from 
multiple sampling of same homogenous sample in given 
conditions. 
• The term intraday precision (repeatability) refers to the use of 
analytical procedure within same laboratory conditions over a 
short period of time by same analyst and same instrument 
where as inter day precision (intermediate precision) refers to 
the use of analytical procedure in same laboratory conditions 
on different days by different analysts. 
• Six injections of ondansateron hydrochloride 50 ppm were 
applied twice after a short interval of time on the same day, the 
procedure was repeated on two consecutive days by different 
analysts and % RSD was reported.
Accuracy 
• Accuracy is the closeness of the test results to that of the true 
value which can be determined in terms of percent recovery. 
• The recovery study was performed at three levels mainly 
80%, 100% and 120% by adding known amount of pure drug 
in to the 50ppm sample solution. 
• The results of recovery studies was tabulated and found 
satisfactory.
Linearity 
• Different concentrations ranging from 10-90 ppm 
were injected in duplicate, out of which five 
concentrations (10, 30, 50, 70, 90, ppm) were 
selected and each concentration was injected in 
duplicate. 
• The mean peak areas were recorded and the 
calibration curve 
• was established by plotting concentration on x-axis 
and peak area on y-axis. 
• The results show that the Beer’s law is obeyed in 
the concentration range of 10-90 ppm.
Range 
• Range is the minimum and maximum concentration of the 
sample at which the analytical procedure gives reproducible 
results. 
• Range can be determined by linearity, accuracy and precision 
studies. 
• The method was found acceptable across wide range of 
concentration (10-90 ppm).
Specificity 
• The retention time of the sample solution of ondansateron 
hydrochloride tablet was found to be 6.0 minutes, which is 
similar to that of the standard solution of Eslicarbazepine 
Acetate. 
• This indicates that there is no drug-excipient interference and 
the drug is properly resolved by this particular method
Robustness 
• Robustness determines the reproducibility of the test result 
with small and deliberate variations in the method parameters. 
• The experiment was carried out by slightly changing the ratio 
of methanol (50±2 ml) in the mobile phase, column oven 
temperature (25.0 ± 0.2oC)and flow rate (1.0±0.1 ml), The 
effectiveness of the deliberate variations was observed on 
retention time of peak. 
• The statistical data gives no significant variations in the above 
parameters indicating that the method is robust.
Analysis of Pharmaceutical API & Dosage form 
• The proposed method was successfully applied for the 
estimation of ondansateron hydrochloride in bulk drug and 
tablet dosage form. 
• The assay results were compiled and chromatogram found 
satisfactory and show there is no interference of the tablet 
matrix with the drug. 
• Low % RSD shows that this methodcan be easily applied for 
the estimation of in Eslicarbazepine Acetate in bulk drug and 
tablet dosage form.
Conclusion 
A high performance liquid chromatography method 
for the quantitative estimation of in bulk drug and 
tablet dosage form has been developed as per the 
requirement of present era. 
Statistical result and low % RSD values indicate that 
the method is precise, accurate, robust, specific and 
can be used as a wide range of concentration.
THANK 
YOU

More Related Content

What's hot

Alaytical research
Alaytical researchAlaytical research
Alaytical research
Ahmed Gayyar
 
Stability indicating rp hplc method development and validation for simultaneo...
Stability indicating rp hplc method development and validation for simultaneo...Stability indicating rp hplc method development and validation for simultaneo...
Stability indicating rp hplc method development and validation for simultaneo...
Rajasekhar
 
Diclofenac rabeprazole hplc
Diclofenac rabeprazole hplcDiclofenac rabeprazole hplc
Diclofenac rabeprazole hplc
Deepak Gadade
 

What's hot (19)

ANAND PPT
ANAND PPTANAND PPT
ANAND PPT
 
RP-HPLC method development for simultaneous estimation of atorvastatin and si...
RP-HPLC method development for simultaneous estimation of atorvastatin and si...RP-HPLC method development for simultaneous estimation of atorvastatin and si...
RP-HPLC method development for simultaneous estimation of atorvastatin and si...
 
Alaytical research
Alaytical researchAlaytical research
Alaytical research
 
Devlopment and validation of rp hplc method for simultaneous ex.
Devlopment and validation of rp hplc method for simultaneous ex.Devlopment and validation of rp hplc method for simultaneous ex.
Devlopment and validation of rp hplc method for simultaneous ex.
 
RP-HPLC Method Development and Validation for the Simultaneous Estimation of ...
RP-HPLC Method Development and Validation for the Simultaneous Estimation of ...RP-HPLC Method Development and Validation for the Simultaneous Estimation of ...
RP-HPLC Method Development and Validation for the Simultaneous Estimation of ...
 
Stability indicating rp hplc method development and validation for simultaneo...
Stability indicating rp hplc method development and validation for simultaneo...Stability indicating rp hplc method development and validation for simultaneo...
Stability indicating rp hplc method development and validation for simultaneo...
 
Sampath
SampathSampath
Sampath
 
Analytical method development and validation for residual solvent of Diltiaze...
Analytical method development and validation for residual solvent of Diltiaze...Analytical method development and validation for residual solvent of Diltiaze...
Analytical method development and validation for residual solvent of Diltiaze...
 
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...
An emerging way of estimation of Olmesartan medoxomil & Hydrochlorothiazide i...
 
Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy
 Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy
Shraddha roll no- 7 -m. pharm final presentation ---rbvrr college of pharmacy
 
Stability indicating method development and validation for the simultaneous e...
Stability indicating method development and validation for the simultaneous e...Stability indicating method development and validation for the simultaneous e...
Stability indicating method development and validation for the simultaneous e...
 
Development and validation of GC-MS method for analysis of chloropyramine hyd...
Development and validation of GC-MS method for analysis of chloropyramine hyd...Development and validation of GC-MS method for analysis of chloropyramine hyd...
Development and validation of GC-MS method for analysis of chloropyramine hyd...
 
Simultaneous estimation and validation for gliclazide(yachita)
Simultaneous estimation and validation for gliclazide(yachita)Simultaneous estimation and validation for gliclazide(yachita)
Simultaneous estimation and validation for gliclazide(yachita)
 
Diclofenac rabeprazole hplc
Diclofenac rabeprazole hplcDiclofenac rabeprazole hplc
Diclofenac rabeprazole hplc
 
Development and Validation of Novel RP-HPLC method for the estimation of Nalo...
Development and Validation of Novel RP-HPLC method for the estimation of Nalo...Development and Validation of Novel RP-HPLC method for the estimation of Nalo...
Development and Validation of Novel RP-HPLC method for the estimation of Nalo...
 
RP-HPLC method development and validation of ritonavir in bulk and pharmaceut...
RP-HPLC method development and validation of ritonavir in bulk and pharmaceut...RP-HPLC method development and validation of ritonavir in bulk and pharmaceut...
RP-HPLC method development and validation of ritonavir in bulk and pharmaceut...
 
Ijpar 12 17
Ijpar 12 17Ijpar 12 17
Ijpar 12 17
 
RP-HPLC Assay Method Validation for the estimation of new Anti-retroviral dru...
RP-HPLC Assay Method Validation for the estimation of new Anti-retroviral dru...RP-HPLC Assay Method Validation for the estimation of new Anti-retroviral dru...
RP-HPLC Assay Method Validation for the estimation of new Anti-retroviral dru...
 
Method development and validation for the simultaneous estimation of sitaglip...
Method development and validation for the simultaneous estimation of sitaglip...Method development and validation for the simultaneous estimation of sitaglip...
Method development and validation for the simultaneous estimation of sitaglip...
 

Viewers also liked

Method Validation: What Are Its Key Parameters
Method Validation:What Are Its Key ParametersMethod Validation:What Are Its Key Parameters
Method Validation: What Are Its Key Parameters
complianceonline123
 
Resilience powerpoint
Resilience powerpointResilience powerpoint
Resilience powerpoint
annieglass
 
Resilience presentation
Resilience presentationResilience presentation
Resilience presentation
Joe Krause
 

Viewers also liked (14)

Aerosols q c
Aerosols q cAerosols q c
Aerosols q c
 
HPLC Method Development & Method Validation (mr.s)
HPLC Method Development & Method Validation (mr.s)HPLC Method Development & Method Validation (mr.s)
HPLC Method Development & Method Validation (mr.s)
 
Method Validation: What Are Its Key Parameters
Method Validation:What Are Its Key ParametersMethod Validation:What Are Its Key Parameters
Method Validation: What Are Its Key Parameters
 
Theory of high performance liquid chromatography ppt
Theory of high performance liquid chromatography pptTheory of high performance liquid chromatography ppt
Theory of high performance liquid chromatography ppt
 
validation and calibration of HPLC
validation and calibration of HPLCvalidation and calibration of HPLC
validation and calibration of HPLC
 
analytical method validation and validation of hplc
analytical method validation and validation of hplcanalytical method validation and validation of hplc
analytical method validation and validation of hplc
 
TURMERIC PROCESSING
TURMERIC PROCESSING TURMERIC PROCESSING
TURMERIC PROCESSING
 
Curcumin
Curcumin Curcumin
Curcumin
 
Analytical Method Validation
Analytical Method ValidationAnalytical Method Validation
Analytical Method Validation
 
Resilience: how to build resilience in your people and your organization
Resilience: how to build resilience in your people and your organizationResilience: how to build resilience in your people and your organization
Resilience: how to build resilience in your people and your organization
 
Build your resilience
Build your resilience Build your resilience
Build your resilience
 
Resilience powerpoint
Resilience powerpointResilience powerpoint
Resilience powerpoint
 
Resilience presentation
Resilience presentationResilience presentation
Resilience presentation
 
HPLC
HPLCHPLC
HPLC
 

Similar to Love ppt

Similar to Love ppt (20)

Research article discussion for simultaneous method HPLC estimation
Research article discussion for simultaneous method HPLC estimationResearch article discussion for simultaneous method HPLC estimation
Research article discussion for simultaneous method HPLC estimation
 
Development and validation of method for simultaneous estimation of hydrochlo...
Development and validation of method for simultaneous estimation of hydrochlo...Development and validation of method for simultaneous estimation of hydrochlo...
Development and validation of method for simultaneous estimation of hydrochlo...
 
Spectrophotometric analysis of Drugs
Spectrophotometric analysis of DrugsSpectrophotometric analysis of Drugs
Spectrophotometric analysis of Drugs
 
Stability indicating method development and validation for the estimation of ...
Stability indicating method development and validation for the estimation of ...Stability indicating method development and validation for the estimation of ...
Stability indicating method development and validation for the estimation of ...
 
RP-HPLC method development & validation for estimation of Flecainide acetate ...
RP-HPLC method development & validation for estimation of Flecainide acetate ...RP-HPLC method development & validation for estimation of Flecainide acetate ...
RP-HPLC method development & validation for estimation of Flecainide acetate ...
 
Analytical Techniques in Pharmacology
Analytical Techniques in PharmacologyAnalytical Techniques in Pharmacology
Analytical Techniques in Pharmacology
 
B03708012
B03708012B03708012
B03708012
 
JOURNAL CLUB PRESENTATION (20L81S0701-PA)
JOURNAL CLUB PRESENTATION (20L81S0701-PA)JOURNAL CLUB PRESENTATION (20L81S0701-PA)
JOURNAL CLUB PRESENTATION (20L81S0701-PA)
 
zidovudine hplc method
zidovudine hplc method zidovudine hplc method
zidovudine hplc method
 
Bulk and pharmaceutical Linagliptin.pptx
Bulk and pharmaceutical Linagliptin.pptxBulk and pharmaceutical Linagliptin.pptx
Bulk and pharmaceutical Linagliptin.pptx
 
new project kowsalya.pptx
new project kowsalya.pptxnew project kowsalya.pptx
new project kowsalya.pptx
 
Pharmaceutical analysis, tech & implementation
Pharmaceutical analysis, tech & implementationPharmaceutical analysis, tech & implementation
Pharmaceutical analysis, tech & implementation
 
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION HPLC UV
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION HPLC UVANALYTICAL METHOD DEVELOPMENT AND VALIDATION HPLC UV
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION HPLC UV
 
Analytical method development and validation
Analytical method development and validationAnalytical method development and validation
Analytical method development and validation
 
04_IJPBA_1896_20.pdf
04_IJPBA_1896_20.pdf04_IJPBA_1896_20.pdf
04_IJPBA_1896_20.pdf
 
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLCSimultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
 
THE JOURNAL CLUB venkat 2 pharmaceutical analysis
THE JOURNAL CLUB venkat 2 pharmaceutical analysisTHE JOURNAL CLUB venkat 2 pharmaceutical analysis
THE JOURNAL CLUB venkat 2 pharmaceutical analysis
 
Method Development and Validation on Etomidate injection by RP-HPLC
Method Development and Validation on Etomidate injection by RP-HPLCMethod Development and Validation on Etomidate injection by RP-HPLC
Method Development and Validation on Etomidate injection by RP-HPLC
 
VANILLYLMANDELIC ACID ESTIMATION
VANILLYLMANDELIC ACID ESTIMATIONVANILLYLMANDELIC ACID ESTIMATION
VANILLYLMANDELIC ACID ESTIMATION
 
HPLC METHOD ADAPALENE & BENZOYL PEROXIDE
HPLC METHOD ADAPALENE & BENZOYL PEROXIDEHPLC METHOD ADAPALENE & BENZOYL PEROXIDE
HPLC METHOD ADAPALENE & BENZOYL PEROXIDE
 

Recently uploaded

Pests of sugarcane_Binomics_IPM_Dr.UPR.pdf
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdfPests of sugarcane_Binomics_IPM_Dr.UPR.pdf
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdf
PirithiRaju
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
YOGESH DOGRA
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
THYROID-PARATHYROID medical surgical nursing
THYROID-PARATHYROID medical surgical nursingTHYROID-PARATHYROID medical surgical nursing
THYROID-PARATHYROID medical surgical nursing
Jocelyn Atis
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
AADYARAJPANDEY1
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 

Recently uploaded (20)

EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdf
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdfPests of sugarcane_Binomics_IPM_Dr.UPR.pdf
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdf
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
 
FAIRSpectra - Towards a common data file format for SIMS images
FAIRSpectra - Towards a common data file format for SIMS imagesFAIRSpectra - Towards a common data file format for SIMS images
FAIRSpectra - Towards a common data file format for SIMS images
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
THYROID-PARATHYROID medical surgical nursing
THYROID-PARATHYROID medical surgical nursingTHYROID-PARATHYROID medical surgical nursing
THYROID-PARATHYROID medical surgical nursing
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
SAMPLING.pptx for analystical chemistry sample techniques
SAMPLING.pptx for analystical chemistry sample techniquesSAMPLING.pptx for analystical chemistry sample techniques
SAMPLING.pptx for analystical chemistry sample techniques
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
National Biodiversity protection initiatives and Convention on Biological Di...
National Biodiversity protection initiatives and  Convention on Biological Di...National Biodiversity protection initiatives and  Convention on Biological Di...
National Biodiversity protection initiatives and Convention on Biological Di...
 
word2vec, node2vec, graph2vec, X2vec: Towards a Theory of Vector Embeddings o...
word2vec, node2vec, graph2vec, X2vec: Towards a Theory of Vector Embeddings o...word2vec, node2vec, graph2vec, X2vec: Towards a Theory of Vector Embeddings o...
word2vec, node2vec, graph2vec, X2vec: Towards a Theory of Vector Embeddings o...
 
Predicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdfPredicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdf
 
A Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on EarthA Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on Earth
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 

Love ppt

  • 1. Presentation on “Method Development and validation for the Quantitative Estimation of ONDANSETRON HYDROCHLORIDE by HPTLC in Bulk Drug & Tablet Dosage Form” By: LOVE KUMAR M.Sc Biotechnology
  • 2. What is Drug? • Drug is substance meant for cure, mitigation prevention or treatment of disease. • A drug is a substance which may have medicinal, intoxicating, performance enhancing or other effects when taken or put into a human body.
  • 3. ONDANSETRON HYDROCHLORIDE • Ondansetron hydrochloride is a serotonin 5- HT-3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting
  • 4. Mechanism of action • It effects on both peripheral and central nerves system by reducing the activity of the vagus nerve which deactivate the vomiting centre in the medulla oblongota and also block serotonin receptors in the chemoreceptor trigger zone • It also has little effect on vomiting caused by motion sickness.
  • 5. ondansetron hydrochloride • 1. Nature : Amorphous • 2. Colour : White • 3. Odour : Odourless • 4. Taste : Bitter • 5. Melting point : 1200 C • 6. Solubility : freely soluble in methanol
  • 6. Method Development • Existing method may not be suitable. • Unreliable • Expensive • Time consuming • Not Easily automated • New instrumentation technique may provide improved methods
  • 7. CHROMATOGRAPHY • The term ‘Chromatography’ covers those processes aimed at the separation of the various species of a mixture on the basis of their distribution characteristics between a stationary and a mobile phase.
  • 8. Different modes of chromatography are as follows: • Normal Phase Chromatography • Reversed Phase Chromatography • Reversed Phase – Ion pair Chromatography • Ion Chromatography • Ion-Exchange Chromatography • Affinity Chromatography • Size Exclusion Chromatography
  • 9. Instrumentation Pump Injector Silica Plate Detector Gradient Controller Mobile Phases •
  • 10. Materials and Method Reagents and Chemicals: • Sample and working standards of ondansetron hydrochloride were obtained from Sun Pharma Pvt Ltd, HPLC grade methanol was purchased from E.Merck and ammonium acetate of analytical reagent grade was purchased from Sisco Research Laboratories. Instrumentation: • Uv –vis spectrophotometer is of backman DU640B • Pump - water 600controller pump • Auto sampler – water 717 plus • Uv detector – water 486 • Software – millinium 32 .
  • 11. Chromatographic Conditions • The elution of ondansateron hydrochloride was obtained by running HPTLC in isocratic mode using methanol and tiriethylamine – glacial acetic acid in a ratio of 9.5:0.5 v/v, flowrate was maintained at 1.0 ml per minute with run time of 10 minutes. • The Rf for ondansateron hydrochloride was obtained at 7.7 and detection was performed at 309 nm. • Mobile phase was previously filtered through what mann filter paper no 41.
  • 12. • Preparation of Standard Stock solution • Stock solution (1000 ppm) of ondansateron hydrochloride was prepared by dissolving 100 mg of Eslicarbazepine Acetate standard in methanol in a 100 ml volumetric flask, the volume was made up to the mark with methanol. • This stock solution was further diluted to obtain desired concentrations. • Preparation of Sample solution: • Weighed 20 tablets of ondansateron hydrochloride (labelled claim 400 mg of ondansateron hydrochloride ) and average weight was calculated. • The tablets were crushed to get homogenous powder and a quantity equivalent to 100 mg was weighed in a volumetric flask. • The powder was then allowed to dissolve in methanol by sonication. Make up the volume to the mark with methanol and filter the solution through 0.2 μm filters. • The filtrate was diluted to obtain desired concentrations.
  • 13. Method Development: Selection of wavelength • Appropriate dilutions of ondansateron hydrochloride was prepared from the stock solution,which were scanned over a range of 200-400 nm and the UV spectrum was . • The maximum absorbance was found at 309 nm.
  • 14. Method Validation • Linearity • Sensitivity • Precision • Accuracy • Limit of Detection (LOD) • Limit of Quantitation (LOQ) • Ruggedness • Robustness • Stability • System Suitability
  • 15. Precision • Precision of an analytical procedure referred to degree of scatterness between a series of observations obtained from multiple sampling of same homogenous sample in given conditions. • The term intraday precision (repeatability) refers to the use of analytical procedure within same laboratory conditions over a short period of time by same analyst and same instrument where as inter day precision (intermediate precision) refers to the use of analytical procedure in same laboratory conditions on different days by different analysts. • Six injections of ondansateron hydrochloride 50 ppm were applied twice after a short interval of time on the same day, the procedure was repeated on two consecutive days by different analysts and % RSD was reported.
  • 16. Accuracy • Accuracy is the closeness of the test results to that of the true value which can be determined in terms of percent recovery. • The recovery study was performed at three levels mainly 80%, 100% and 120% by adding known amount of pure drug in to the 50ppm sample solution. • The results of recovery studies was tabulated and found satisfactory.
  • 17. Linearity • Different concentrations ranging from 10-90 ppm were injected in duplicate, out of which five concentrations (10, 30, 50, 70, 90, ppm) were selected and each concentration was injected in duplicate. • The mean peak areas were recorded and the calibration curve • was established by plotting concentration on x-axis and peak area on y-axis. • The results show that the Beer’s law is obeyed in the concentration range of 10-90 ppm.
  • 18. Range • Range is the minimum and maximum concentration of the sample at which the analytical procedure gives reproducible results. • Range can be determined by linearity, accuracy and precision studies. • The method was found acceptable across wide range of concentration (10-90 ppm).
  • 19. Specificity • The retention time of the sample solution of ondansateron hydrochloride tablet was found to be 6.0 minutes, which is similar to that of the standard solution of Eslicarbazepine Acetate. • This indicates that there is no drug-excipient interference and the drug is properly resolved by this particular method
  • 20. Robustness • Robustness determines the reproducibility of the test result with small and deliberate variations in the method parameters. • The experiment was carried out by slightly changing the ratio of methanol (50±2 ml) in the mobile phase, column oven temperature (25.0 ± 0.2oC)and flow rate (1.0±0.1 ml), The effectiveness of the deliberate variations was observed on retention time of peak. • The statistical data gives no significant variations in the above parameters indicating that the method is robust.
  • 21. Analysis of Pharmaceutical API & Dosage form • The proposed method was successfully applied for the estimation of ondansateron hydrochloride in bulk drug and tablet dosage form. • The assay results were compiled and chromatogram found satisfactory and show there is no interference of the tablet matrix with the drug. • Low % RSD shows that this methodcan be easily applied for the estimation of in Eslicarbazepine Acetate in bulk drug and tablet dosage form.
  • 22. Conclusion A high performance liquid chromatography method for the quantitative estimation of in bulk drug and tablet dosage form has been developed as per the requirement of present era. Statistical result and low % RSD values indicate that the method is precise, accurate, robust, specific and can be used as a wide range of concentration.